Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-030190

General Counsel and Secretary sold 3,947 shares at an average $77.15 ($304,515)

  • General Counsel and Secretary acquired 7,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KASINGER JAMES R. General Counsel and Secretary 2024-03-10 Option exercise +5,500 62,871 D
KASINGER JAMES R. General Counsel and Secretary 2024-03-11 Sale −2,801 $78.26 $219,206 60,070 D
KASINGER JAMES R. General Counsel and Secretary 2024-03-11 Option exercise +2,250 62,320 D
KASINGER JAMES R. General Counsel and Secretary 2024-03-12 Sale −1,146 $74.44 $85,308 61,174 D
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2024-03-10 Option exercise · Restricted Stock Units −5,500 16,500 D
KASINGER JAMES R. General Counsel and Secretary 2024-03-11 Option exercise · Restricted Stock Units −2,250 2,250 D
Open-market sales · 3,947 sh · avg $77.15 · $304,515
Loading xslF345X05/ownership.xml…